Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ziziphus jujuba (Jujuboside A).
Ziziphus jujuba exerts sedative and anxiolytic effects primarily through the modulation of GABAergic signaling and the inhibition of excitatory glutamate pathways within the hippocampal CA1 region.
11211718
399.4 g/mol
-0.1
6-cyclohexylsulfonyl-1-oxido-3-(1-oxidopyridin-1-ium-4-yl)sulfonylpyridazin-1-ium
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ziziphus jujuba (Jujuboside A) across standard consumer modalities.
The hygroscopic nature of concentrated jujube extracts requires moisture-resistant excipients to prevent clumping and degradation of saponin content.
High concentrations of jujubosides can impart a distinct bitterness and astringency that requires complex masking agents to maintain organoleptic quality in pectin-based matrices.
The high therapeutic dose required for sedative efficacy exceeds the typical 50mg payload capacity of standard thin-film polymer matrices.
Ready to launch a product featuring Ziziphus jujuba (Jujuboside A)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Ziziphus jujuba (Jujuboside A) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Ziziphus jujuba (Jujuboside A) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation